Wolverine Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Wolverine Trading’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,400	Closed	-$451K	–	6078
2024 Q4	$451K	Sell	5,400 -6,200	-53%	-$509K	﹤0.01%	3506
2024 Q3	$850K	Sell	11,600 -4,600	-28%	-$346K	﹤0.01%	2519
2024 Q2	$1.11M	Buy	16,200 +1,300	+9%	+$90.2K	﹤0.01%	2104
2024 Q1	$1.03M	Buy	14,900 +11,300	+314%	+$777K	﹤0.01%	2180
2023 Q4	$258K	Buy	+3,600	New	+$207K	﹤0.01%	3609
2023 Q2	–	Sell	-3,600	Closed	-$202K	–	5112
2023 Q1	$202K	Sell	3,600 -200	-5%	-$9.67K	﹤0.01%	3403
2022 Q4	$201K	Sell	3,800 -4,100	-52%	-$205K	﹤0.01%	3145
2022 Q3	$357K	Buy	+7,900	New	+$413K	﹤0.01%	2975
2022 Q2	–	Sell	-4,300	Closed	-$259K	–	5963
2022 Q1	$259K	Sell	4,300 -2,500	-37%	-$130K	﹤0.01%	4092
2021 Q4	$354K	Buy	+6,800	New	+$286K	﹤0.01%	3929
2021 Q1	–	Sell	-10,400	Closed	-$335K	–	6524
2020 Q4	$335K	Sell	10,400 -9,700	-48%	-$255K	﹤0.01%	3632
2020 Q3	$513K	Buy	20,100 +2,900	+17%	+$66.2K	﹤0.01%	2790
2020 Q2	$433K	Buy	17,200 +1,700	+11%	+$34.4K	﹤0.01%	2905
2020 Q1	$245K	Sell	15,500 -139,700	-90%	-$3.03M	﹤0.01%	3455
2019 Q4	$5.22M	Buy	155,200 +102,000	+192%	+$1.22M	0.01%	1058
2019 Q3	$399K	Buy	53,200 +6,600	+14%	+$63.3K	﹤0.01%	2875
2019 Q2	$605K	Buy	46,600 +3,300	+8%	+$42.3K	﹤0.01%	2519
2019 Q1	$527K	Buy	43,300 +600	+1%	+$7.67K	﹤0.01%	2715
2018 Q4	$481K	Sell	42,700 -46,300	-52%	-$747K	﹤0.01%	2673
2018 Q3	$1.93M	Buy	89,000 +47,900	+117%	+$1M	﹤0.01%	1707
2018 Q2	$865K	Hold	41,100	–	–	﹤0.01%	2421
2018 Q1	$865K	Buy	41,100 +22,000	+115%	+$429K	﹤0.01%	2421
2017 Q4	$277K	Sell	19,100 -9,000	-32%	-$139K	﹤0.01%	3735
2017 Q3	$443K	Buy	28,100 +17,600	+168%	+$258K	﹤0.01%	2753
2017 Q2	$133K	Sell	10,500 -2,100	-17%	-$24.3K	﹤0.01%	3803
2017 Q1	$205K	Buy	12,600 +800	+7%	+$11.6K	﹤0.01%	3508
2016 Q4	$178K	Sell	11,800 -43,100	-79%	-$609K	﹤0.01%	3828
2016 Q3	$847K	Buy	54,900 +14,700	+37%	+$594K	﹤0.01%	2045
2016 Q2	$1.5M	Buy	+40,200	New	+$1.44M	0.01%	1296